Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial von Weiss, J.M., Csoszi, T., Maglakelidze, M., Hoyer, R.J., Beck, J.T., Domine Gomez, M., Lowczak, A., Aljumaily, R., Rocha Lima, C.M., Boccia, R.V., Hanna, W., Nikolinakos, P., Chiu, V.K., Owonikoko, T.K., Schuster, S.R., Hussein, M.A., Richards, D.A., Sawrycki, P., Bulat, I., Hamm, J.T., Hart, L.L., Adler, S., Antal, J.M., Lai, A.Y., Sorrentino, J.A., Yang, Z., Malik, R.K., Morris, S.R., Roberts, P.J., Dragnev, K.H.

Volltext

Use of intranasal povidone-iodine packing in the management of infectious rhinosinusitis in three cats von Sorrentino, Paul J, MacArthur, Sandra L

Volltext

Is there a benefit for health care workers in testing HIV, HCV and HBV in routine before elective arthroplasty? von Winkelmann, M, Sorrentino, J.-N, Klein, M, Macke, C, Mommsen, P, Brand, S, Schröter, C, Krettek, C, Zeckey, C

Volltext

Trilaciclib (trila) preserves and enhances immune system function in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy von Sorrentino, J.A., Lai, A., Weiss, J.M., Dragnev, K.H., Owonikoko, T.K., Adler, S., Antal, J.M., Malik, R.K., Roberts, P.J.

Volltext

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program von McKillip, RP, Borden, BA, Galecki, P, Ham, SA, Patrick‐Miller, L, Hall, JP, Hussain, S, Danahey, K, Siegler, M, Sorrentino, MJ, Sacro, Y, Davis, AM, Rubin, DT, Lipstreuer, K, Polonsky, TS, Nanda, R, Harper, WR, Koyner, JL, Burnet, DL, Stadler, WM, Ratain, MJ, Meltzer, DO, O'Donnell, PH

Volltext

Implications of the Metabolic Syndrome: the New Epidemic von Sorrentino, Matthew J.

Volltext

Est-il utile pour les soignants de tester systématiquement VIH, HCV, et HBV avant une chirurgie programmée ? von Winkelmann, M., Sorrentino, J.-N., Klein, M., Macke, C., Mommsen, P., Brand, S., Schröter, C., Krettek, C., Zeckey, C.

Volltext

The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery von Parker Ward, R., Leeper, Nicholas J., Kirkpatrick, James N., Lang, Roberto M., Sorrentino, Matthew J., Williams, Kim A.

Volltext

Circular RNAs are abundant, conserved, and associated with ALU repeats von Jeck, William R, Sorrentino, Jessica A, Wang, Kai, Slevin, Michael K, Burd, Christin E, Liu, Jinze, Marzluff, William F, Sharpless, Norman E

Volltext

Pharmacogenomics and cardiology: improving treatment with existing drugs von Sorrentino, Matthew J, O'Donnell, Peter H

Volltext

Bleeding Risk Prediction Models in Atrial Fibrillation von Thomas, Isac C., Sorrentino, Matthew J.

Volltext

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization von Patel, Manesh R., MD, FACC, Bailey, Steven R., MD, FACC, FSCAI, FAHA, Bonow, Robert O., MD, MACC, MACP, FAHA, Chambers, Charles E., MD, FACC, FSCAI, Chan, Paul S., MD, MSc, Dehmer, Gregory J., MD, FACC, FSCAI, FACP, FAHA, Kirtane, Ajay J., MD, SM, FACC, FSCAI, Samuel Wann, L., MD, MACC, Parker Ward, R., MD, FACC, FASE, FASNC, Douglas, Pamela S., MD, MACC, FAHA, FASE, Altus, Philip, MD, MACP, Barnard, Denise D., MD, FACC, Blankenship, James C., MD, MACC, FSCAI, Casey, Donald E., MD, MPH, MBA, FACP, FAHA, Dean, Larry S., MD, FACC, FAHA, FSCAI, Fazel, Reza, MD, MSc, FACC, Gilchrist, Ian C., MD, FACC, FSCAI, FCCM, Kavinsky, Clifford J., MD, PhD, FACC, FSCAI, Lakoski, Susan G., MD, MS, Le, D. Elizabeth, MD, FACC, FASE, Lesser, John R., MD, FACC, FSCAI, FSCCT, Levine, Glenn N., MD, FACC, FAHA, Mehran, Roxana, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI, Russo, Andrea M., MD, FACC, FHRS, Sorrentino, Matthew J., MD, FACC, Williams, Mathew R., MD, FACC, Wong, John B., MD, FACP, Wolk, Michael J., MD, MACC, Hendel, Robert C., MD, FACC, FAHA, FASNC, Kramer, Christopher M., MD, FACC, FAHA, Min, James K., MD, FACC, Shaw, Leslee, PhD, FACC, FASNC, Stainback, Raymond F., MD, FACC, FASE, Allen, Joseph M., MA

Volltext

Trilaciclib (G1T28), a CDK4/6 inhibitor, enhances the efficacy of combination chemotherapy and immune checkpoint inhibitor treatment in preclinical models von Roberts, P.J., Lai, A.Y., Sorrentino, J.A., Malik, R.K.

Volltext

The ACCOMPLISH Trial: Will First-Line Hypertension Therapy Change? von Sorrentino, Matthew J.

Volltext

29INTrilaciclib (G1T28), a CDK4/6 inhibitor, enhances the efficacy of combination chemotherapy and immune checkpoint inhibitor treatment in preclinical models von Roberts, P J, Lai, A Y, Sorrentino, J A, Malik, R K

Volltext

Aspirin Is Efficacious for the Treatment of Acute Migraine von Lipton, Richard B., Goldstein, Jerome, Baggish, Jeffrey S., Yataco, Alberto R., Sorrentino, James V., Quiring, John N.

Volltext

Premedication with Oral and Transdermal Clonidine Provides Safe and Efficacious Postoperative Sympatholysis von Ellis, John E., Drijvers, Greet, Pedlow, Steven, Laff, Scott P., Sorrentino, Matthew J., FOSS, Joseph F., Shah, Manish, Busse, J. R., Mantha, Srinivas, McKinsey, James F., Osinski, Joachim, Thisted, Ronald A., Roizen, Michael F.

Volltext

Est-il utile pour les soignants de tester systématiquement VIH, HCV, et HBV avant une chirurgie programmée ? von Winkelmann, M., Sorrentino, J.-N., Klein, M., Macke, C., Mommsen, P., Brand, S., Schröter, C., Krettek, C., Zeckey, C.

Volltext

1671PTrilaciclib (trila) preserves and enhances immune system function in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy von Sorrentino, J A, Lai, A, Weiss, J M, Dragnev, K H, Owonikoko, T K, Adler, S, Antal, J M, Malik, R K, Roberts, P J

Volltext

1537PLerociclib (G1T38), an oral CDK4/6 inhibitor, dosed continuously in combination with osimertinib for EGFRmut non-small cell lung cancer: Initial phase Ib results von Berz, D, Spira, A, Gadgeel, S M, Anderson, I C, Goldman, J W, Thompson, J, Foster, T, Pritchett, Y L, Cisneros, C G, Li, C, Sorrentino, J A, Malik, R, Beelen, A P

Volltext